Draig nets $65M to advance depression drug aimed at rebuilding synapses

Ivana Magovčević-Liebisch, Draig Therapeutics CEO July 14, 2026 07:30 AM EDT FinancingStartups Draig nets $65M to ad­vance de­pres­sion drug aimed at re­build­ing synaps­es Ayisha Sharma News Reporter Draig Ther­a­peu­tics has se­cured $65 mil­lion in an over­sub­scribed Se­ries B raise to ad­vance a pipeline of neu­ropsy­chi­a­try drugs, in­clud­ing its … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER